PlainRecalls
FDA Drug Low Class III Terminated

Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmington, DE 19850 by: Patheon Pharmaceuticals, Inc. Cincinnati OH 45237 Product of Switzerland NDC 0310-0657-58

Reported: March 14, 2018 Initiated: February 23, 2018 #D-0585-2018

Product Description

Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmington, DE 19850 by: Patheon Pharmaceuticals, Inc. Cincinnati OH 45237 Product of Switzerland NDC 0310-0657-58

Reason for Recall

Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).

Details

Units Affected
18056 bottles
Distribution
Nationwide
Location
Wilmington, DE

Frequently Asked Questions

What product was recalled?
Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmington, DE 19850 by: Patheon Pharmaceuticals, Inc. Cincinnati OH 45237 Product of Switzerland NDC 0310-0657-58. Recalled by AstraZeneca Pharmaceuticals LP. Units affected: 18056 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
Which agency issued this recall?
This recall was issued by the FDA Drug on March 14, 2018. Severity: Low. Recall number: D-0585-2018.